| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/15/2007 | US20070037735 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 02/15/2007 | US20070037606 Transmitter of wireless microphone, receiver for wireless microphone, portable information communication device, and wireless microphone communication system |
| 02/15/2007 | US20070037249 Molecules that block viral infectivity and methods of use thereof |
| 02/15/2007 | US20070037141 comprise DP178 peptide corresponding to amino acids 638 to 673 of the HIV-1LAI gp41 protein; inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells |
| 02/15/2007 | US20070037136 Harvesting, separating, culturing and exposing tissue to antiproliferative agents, monitoring variation in tissue propagation; immunotherapeutics; wound healing agents |
| 02/15/2007 | US20070036875 Use of allicin as preservative, as disinfectant, as antimicrobial or as biocidal agent |
| 02/15/2007 | US20070036854 Therapeutic applications of pro-apoptotic benzodiazepines |
| 02/15/2007 | US20070036805 Comprising a specific binding agent which is an F(ab')2 or F(ab)2 antibody fragment that specifically binds a target toxin, and a second specific binding agent that comprises a small binding antibody fragment that binds the target toxin; Botulinum toxin |
| 02/15/2007 | US20070036783 Antibody complexes |
| 02/15/2007 | US20070036776 Bacterial signaling molecules that down-regulate pathogenic bacterial virulence properties |
| 02/15/2007 | US20070036774 Liver engrafting cells, assays, and uses thereof |
| 02/15/2007 | US20070036744 Treatment or prevention of respiratory viral infections with alpha thymosin peptides |
| 02/15/2007 | DE102005037733A1 Adeninderivate Adenine derivatives |
| 02/15/2007 | CA2618631A1 Method for producing cercosporamide |
| 02/15/2007 | CA2618554A1 Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system |
| 02/15/2007 | CA2617960A1 A novel nucleic acid encoding a novel protein of candida albicans and uses thereof |
| 02/15/2007 | CA2616977A1 Oxazolidinone-quinolone hybrids as antibacterial compounds |
| 02/15/2007 | CA2613482A1 Methods and compositions for diagnosis and treatment of influenza |
| 02/15/2007 | CA2605481A1 Phosphonated fluoroquinolones, antibacterial analogs thereof, and methods for the prevention and treatment of bone and joint infections |
| 02/14/2007 | EP1752538A1 Human bikunin |
| 02/14/2007 | EP1752469A2 Long lasting fusion peptide inhibitors for HIV infection |
| 02/14/2007 | EP1752455A2 Chemokine receptor binding heterocyclic compounds |
| 02/14/2007 | EP1752189A2 Microprojection array having a beneficial agent containing coating |
| 02/14/2007 | EP1752160A2 Epitope sequences |
| 02/14/2007 | EP1752159A1 Medicinal composition and therapeutic method |
| 02/14/2007 | EP1752148A2 Substituted phenethylsulfones for the treatment of inflammatory, infectious, immunological or malignant disease |
| 02/14/2007 | EP1751291A1 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
| 02/14/2007 | EP1751165A1 4-substituted 1,5-dihydro-pyrido(3,2-b)indol-2-ones |
| 02/14/2007 | EP1751161A1 Diazaindole-dicarbonyl-piperazinyl antiviral agents |
| 02/14/2007 | EP1751157A1 Inhibitors of the hiv integrase enzyme |
| 02/14/2007 | EP1751156A1 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido(3,2-b)indol-2-ones useful as anti-infective pharmaceutical agents |
| 02/14/2007 | EP1751155A1 Substituted azachinazolines having an antiviral action |
| 02/14/2007 | EP1751154A1 5-substituted 1-phenyl-1,5-dihydro-pyrido[3,2-b] indol-2-ones and analogs as anti-virals |
| 02/14/2007 | EP1751119A1 Novel fused heterocycles and uses thereof |
| 02/14/2007 | EP1751118A1 Pyrimidines for use as plk inhibitors |
| 02/14/2007 | EP1751094A2 Beta-peptides |
| 02/14/2007 | EP1750765A2 Antimycobacterial pharmaceutical composition comprising an antitubercular drug |
| 02/14/2007 | EP1750747A1 Soluble lfa-3 polypeptide for treating viral disorders |
| 02/14/2007 | EP1750745A1 Methods of inhibiting proinflammatory cytokine expression using ghrelin |
| 02/14/2007 | EP1750744A1 Medicament for the treatment of fungal infections, particularly aspergillosis |
| 02/14/2007 | EP1750726A2 Spermicidal and virucidal properties of various forms of sophorolipids |
| 02/14/2007 | EP1750718A1 Acyclovir formulations |
| 02/14/2007 | EP1750713A1 Use of imatinib to treat liver disorders and viral infections |
| 02/14/2007 | EP1750708A1 Combinations of substituted 1-phenyl-1,5-dihydro-pyrido- [3,2-b] indol-2-ones and other hiv inhibitors |
| 02/14/2007 | EP1750700A1 Liquid preparation for veterinary medicine, method for the production thereof, and use of the same |
| 02/14/2007 | EP1750692A2 Method of tonic treatment with oxyphenbutazone derivatives |
| 02/14/2007 | EP1750691A2 Compounds for treatment of aids and other diseases |
| 02/14/2007 | EP1687013B1 Drug, comprising prunus armenica, cocos nucifera and humulus lupulus |
| 02/14/2007 | EP1536777B1 Use of nf-kappa b inhibitors for the treatment of mastitis |
| 02/14/2007 | EP1507514B1 Controlled release compositions of estradiol metabolites |
| 02/14/2007 | EP1417228B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/14/2007 | EP1395554B1 Substituted carbazoles as inhibitors of spla2 |
| 02/14/2007 | EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/14/2007 | EP1343757B1 Indole derivatives |
| 02/14/2007 | EP1341790B1 Sulfonamido ether substituted imidazoquinolines |
| 02/14/2007 | EP1280515B1 Pharmaceutical compositions comprising cannabis |
| 02/14/2007 | EP1278763B1 3-nitrogen-6,7-dioxygen steroids and uses related thereto |
| 02/14/2007 | EP1260590B1 Method of screening substance specifically inhibiting non-mevalonate pathway |
| 02/14/2007 | EP1143976B9 Beta-d-2', 3' -didehydro-2', 3' -dideoxy-5-fluorocytidine for use in the treatment of hiv infections |
| 02/14/2007 | EP1128813B1 An inhalation system |
| 02/14/2007 | EP1126836B1 Benzamide potassium channel inhibitors |
| 02/14/2007 | EP1066055B1 Horse DNA vaccines containing the adjuvant acrylic acid, methacrylic acid or EMA (R) |
| 02/14/2007 | EP1044983B1 Antibiotic tkr2999, process for the preparation thereof and microbe |
| 02/14/2007 | CN1914225A HCV NS-3 serine protease inhibitors |
| 02/14/2007 | CN1914224A HCV NS-3 serine protease inhibitors |
| 02/14/2007 | CN1914207A Azepinoindole derivatives as pharmaceutical agents |
| 02/14/2007 | CN1914196A 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratiory syncytial virus replication |
| 02/14/2007 | CN1913903A Remedy for external use for skin and mucosal injuries caused by viral infection |
| 02/14/2007 | CN1913890A Compositions substantially free of galactomannan containing piperacillin and tazobactam |
| 02/14/2007 | CN1913889A Compositions comprising HIV protease inhibitor and cytochrome P450 enzyme activity inhibitor |
| 02/14/2007 | CN1913887A Combination of voriconazole and an antifungal CYP2C19 inhibitor |
| 02/14/2007 | CN1912141A Identification of genes |
| 02/14/2007 | CN1912112A Recombinant infectious non-segmented negative strand rna virus |
| 02/14/2007 | CN1912093A Holly tonic wine |
| 02/14/2007 | CN1911963A SARS neutralization antibody and application |
| 02/14/2007 | CN1911960A Chlamydia protein, gene sequence and uses thereof |
| 02/14/2007 | CN1911953A Podophyllum kind compound and its use |
| 02/14/2007 | CN1911931A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 02/14/2007 | CN1911930A Chemokine receptor anagonists, methods and use therefor |
| 02/14/2007 | CN1911927A Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf alpha levels |
| 02/14/2007 | CN1911922A Compound separated from petroleum ether extract of glycyrrhiza legume bacteria strain CCNWGX022 fermentation liquid |
| 02/14/2007 | CN1911449A Cholesterol phosphononucleoside analogue |
| 02/14/2007 | CN1911445A Grippe primary generation susliks kidney cell multivalent raccine and its preparation method |
| 02/14/2007 | CN1911444A Typhoid, paratyphoid ectoblast protein vaccine |
| 02/14/2007 | CN1911443A Vaccine composition comprising tumor antigen and adjunvant composition |
| 02/14/2007 | CN1911442A Lysostaphin freeze dried powder used for preventing and treating trauma surface infestation |
| 02/14/2007 | CN1911439A Orally administered peptides to ameliorate atherosclerosis |
| 02/14/2007 | CN1911411A Traditional Chinese medicine prepn. for treating nephrotuberculosis |
| 02/14/2007 | CN1911410A Medicine for treating tuberculosis, and its prepn. method |
| 02/14/2007 | CN1911400A Compound poria cocos prepn., and its prepn. method |
| 02/14/2007 | CN1911351A Foot washing medicine for treating beri-beri, foot-sweat and foot-odour, and its prepn. method |
| 02/14/2007 | CN1911312A External application medicine for treating beri-beri |
| 02/14/2007 | CN1911306A Ointment for treating beri-beri |
| 02/14/2007 | CN1911300A Compound traditional Chinese medicine prepn. for treating chronic reactivation hepatitis B and its prepn. method |
| 02/14/2007 | CN1911278A Soft capsule contg. Bupleurum and Radix scutellariae, prepn. method and use thereof |
| 02/14/2007 | CN1911260A Application of phenolic acids active components from dandelion for inhibiting gynecologic pelvic inflammatory disease |
| 02/14/2007 | CN1911237A Beta - l-2'-deoxy-nucleosides for the treatment of hepatitis b |
| 02/14/2007 | CN1911229A Compounding injection contg. Ticarcillin Disodium and Sulbactam |
| 02/14/2007 | CN1911217A Oral disintegration tablets of Bingpazhe germanium for treating chronic hepatitis and its making method |
| 02/14/2007 | CN1911017A Synergistic microbicidal combination |